Tea Solutions

Tea Solutions, Hara Office Inc. is a Japanese biotechnology company specializing in the research, development, and production of high-purity tea catechins for pharmaceutical and nutraceutical applications. Founded by Dr. Yukihiko Hara, a pioneer in tea chemistry, the company is best known for developing and supplying Polyphenon E, the active pharmaceutical ingredient in Veregen (sinecatechins), which became the first botanical drug approved by the US FDA in 2006. The company's proprietary extraction technology produces standardized green tea extracts, such as Theaphenon E, which are utilized in clinical trials for cancer prevention, metabolic disorders, and viral infections. Tea Solutions operates as a key supplier and consultant for global pharmaceutical companies and research institutions exploring the therapeutic potential of tea-derived compounds.